Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.


 (hē′mə-tō-poi-ē′sĭs, hĭ-măt′ə-) also he·mo·poi·e·sis (hē′mə-poi-ē′sĭs)
The formation of the cellular elements of the blood, including the red blood cells, white blood cells, and platelets, which in adult mammals takes place chiefly in the bone marrow.

he′ma·to·poi·et′ic (-ĕt′ĭk) adj.


(hɪˌmæt oʊ pɔɪˈi sɪs)

also hemopoiesis

the formation of blood.
he•mat`o•poi•et′ic (-ˈɛt ɪk) adj.

hematopoiesis, haematopoiesis

the formation of blood. — hematopoietic, haematopoietic, adj.
See also: Blood and Blood Vessels


(or hemopoiesis) The production of blood cells in red bone marrow.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hematopoiesis - the formation of blood cells in the living body (especially in the bone marrow)
biological process, organic process - a process occurring in living organisms


n. hematopoyesis, hemopoyesis, formación de sangre.
References in periodicals archive ?
WURZBURG, Germany, July 17, 2019 -- Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow.
The drug is composed of recombinant protein stimulating hematopoiesis via acting on the thrombopoietin receptors.
Based on disease condition, the market has been segmented into cancer, diabetes, autoimmune disorder, infectious disease, hematopoiesis, CVD, neurodegenerative, and others.
Takashi NAGASAWA for "Elucidation of Microenvironments Essential for the Maintenance of Hematopoietic Stem Cells, Hematopoiesis and Bone"
TGF-beta 1 and 3 are the principal disease-driving isoforms, while TGF-beta 2 is responsible for normal cardiac function and is a positive regulator of hematopoiesis.
The rapid engraftment, sustained hematopoiesis and accelerated immune recovery observed in these patients enable the initiation of a second cohort of patients to be treated with NiCord as a stand-alone graft.
The disease is characterized by clonal expansion of undifferentiated myeloid precursors, leading to anomalous hematopoiesis and bone marrow failure.
MF is characterized by clonal hematopoiesis, bone marrow stromal changes, and myeloid metaplasia, which cause debilitating symptoms, hepatosplenomegaly, ineffective hematopoiesis, and increased risk of morbidity and mortality because of bone marrow failure, thrombotic/hemorrhagic events, and transformation to acute leukemia (1).
The researchers also describe how they were able to trace the developmental lineage tree of hematopoiesis using the mutation pattern of HSPCs.
Indeed, FANCA ensures interphase and mitosis over hematopoiesis in vivo (7).
The researchers found that more than 50 percent of the 3,055 nonsynonymous mutations detected across 122 evaluable patients with lung cancer were detected in WBC consistent with clonal hematopoiesis. At a specificity of 98 percent, the WGBS, WGS, and targeted assays detected 41, 38, and 51 percent of early-stage (I to IIIA) cancers, and 89, 87, and 89 percent of late-stage (IIIB to IV) cancers.
These mutations are likely the result of natural aging processes (so-called clonal hematopoiesis of indeterminate potential, or CHIP) and will need to be taken into account when developing blood tests for early detection of blood cancers, noted Oxnard.